The association between MTOR (Mechanistic Target Of Rapamycin Kinase) and Renal Cell Carcinoma, Nonpapillary is supported by expert-curated evidence, drawing on a single expert-curated source, which records pathogenic variants.
Sources1
Clinical variants2
Symptoms2
Compounds2
Trials23of 464 via MTOR compounds
Publications0
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.